Jawline Botox (Masseter Botox): Results, Doses Studied and FDA Status
Masseter Botox slims the lower face by relaxing the jaw muscle. What phase 2 and phase 3 trials and a 2026 meta-analysis found, doses studied, side effects, how long it lasts, and why it's still off-label in the US.
Jawline Botox, or masseter Botox, means injecting botulinum toxin into the masseter, the large chewing muscle at the angle of the jaw. As the muscle relaxes and shrinks, the lower face can look slimmer. The short answer: randomized trials show it works, with effects lasting up to about six months, but as of October 2026 it isn't an FDA-approved use in the US. Allergan has applied for approval.
FDA status
Botox Cosmetic's US label covers frown lines, crow's feet, forehead lines and neck bands (label). In August 2026, the FDA accepted Allergan's application to add masseter muscle prominence, supported by two phase 3 studies (AbbVie). Acceptance is not approval, so masseter injections in the US remain off-label for now.
What the trials show
| Study | Design | Key results |
|---|---|---|
| Phase 3 (Sun et al., 2026) | 376 adults with marked masseter prominence; Botox 72 units vs placebo | At day 90, 51.2% improved by 2 grades vs 2.2% on placebo; lower face width shrank by 5.24 mm vs 0.04 mm; benefits lasted through day 180; side effects mostly mild (Sun et al., Aesthet Surg J, 2026) |
| Phase 2 (Carruthers et al., 2025) | 187 adults; 24, 48, 72 or 96 units vs placebo; 12 months | Significant reduction in lower face volume at day 90; similar results with retreatment; no significant changes in jawbone or teeth; smile changes reported in 4 people at 96 units (Carruthers et al., J Am Acad Dermatol, 2025) |
| Meta-analysis (Machado et al., 2026) | 5 randomized trials, 536 participants | Benefit with 48 and 72 units vs placebo; reduced muscle thickness and higher satisfaction; best dose not yet defined (Machado et al., J Plast Reconstr Aesthet Surg, 2026) |
Results timeline
| Time | What to expect |
|---|---|
| First weeks | Muscle begins to relax |
| About 3 months | Main efficacy point in the trials (Sun et al., Aesthet Surg J, 2026) |
| Up to 6 months | Effects sustained in the phase 3 trial |
| After that | Retreatment may be considered; the phase 2 trial retreated at day 180 if needed (Carruthers et al., J Am Acad Dermatol, 2025) |
Doses studied
Trials used 24 to 96 units of onabotulinumtoxinA total, with 48 and 72 units most studied (Machado et al., J Plast Reconstr Aesthet Surg, 2026). Units differ between brands and can't be converted (Botox label).
Side effects
- Most side effects in the phase 3 trial were mild and resolved (Sun et al., Aesthet Surg J, 2026).
- Changes to the smile were reported at the highest dose (96 units) in the phase 2 trial (Carruthers et al., J Am Acad Dermatol, 2025).
- All botulinum toxins carry a boxed warning about spread of toxin effect beyond the injection site (label).
Who is a good candidate?
- A wide lower face caused by a large masseter muscle, confirmed by your injector's exam
- Not for a wide face from fat, bone shape or loose skin; these need different approaches
Teeth grinding (bruxism)
Masseter injections are also used off-label for teeth grinding. The trials above studied appearance, not grinding, so we don't make claims about bruxism relief here. Talk to a dentist or doctor about grinding or jaw pain.
Masseter Botox vs other jawline treatments
| Treatment | Goal |
|---|---|
| Masseter Botox | Slims a wide jaw from muscle bulk |
| Jawline filler | Adds definition and structure; ask which fillers are FDA-approved for the jawline (FDA: dermal fillers) |
| Kybella or liposuction | Reduces fat under the chin |
| Surgery | Bone or significant sagging |
Frequently asked questions
How long does jaw Botox last? Up to about six months in the phase 3 trial.
Will it change my smile? Uncommon, but reported at high doses; an experienced injector matters.
Is the effect permanent? No. Effects were sustained through six months in the phase 3 trial, and retreatment is needed to maintain them.
This article is for educational purposes only and is not medical advice. Talk to a board-certified dermatologist about your situation.
Sources
- Sun J et al. OnabotulinumtoxinA treatment for masseter muscle prominence: 6-month results from a phase 3, randomized, placebo-controlled trial. Aesthet Surg J. 2026. PubMed
- Carruthers J et al. Reduction of masseter muscle prominence after treatment with onabotulinumtoxinA: primary results from a randomized phase 2 study. J Am Acad Dermatol. 2025. PubMed
- Machado GF et al. Efficacy of botulinum toxin for masseter muscle hypertrophy: a systematic review and meta-analysis. J Plast Reconstr Aesthet Surg. 2026. PubMed
- AbbVie. FDA acceptance of sBLA for Botox Cosmetic for masseter muscle prominence, August 2026
- DailyMed. Botox Cosmetic prescribing information
- U.S. Food and Drug Administration. Dermal fillers